Zentalis Pharmaceuticals, Inc. (ZNTL)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20261 patent granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Zentalis Pharmaceuticals, Inc.’s names, not what it holds today.
13 published
0 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Nov 7, 2023 | 11,806,405 | Immunoconjugates and methods | Pharmaceuticals | Zeno Management, Inc. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Aug 21, 2025 | 2025/0262215 | USE OF CYCLIN E1 STATUS AS A PREDICTIVE BIOMARKER FOR TREATING CANCER WITH WEE1 INHIBITORS | Pharmaceuticals | Zeno Management, Inc. |
| Aug 21, 2025 | 2025/0262214 | INTERMITTENT DOSING REGIMEN FOR AZENOSERTIB IN TREATING CANCER | Pharmaceuticals | Zeno Management, Inc. |
| Dec 26, 2024 | 2024/0424124 | IMMUNOCONJUGATES AND METHODS | Pharmaceuticals | Zeno Management, Inc. · patent 12,268,750 granted from it |
| Dec 26, 2024 | 2024/0424123 | IMMUNOCONJUGATES AND METHODS | Pharmaceuticals | Zeno Management, Inc. · patent 12,285,492 granted from it |
| Dec 26, 2024 | 2024/0424122 | IMMUNOCONJUGATES AND METHODS | Pharmaceuticals | Zeno Management, Inc. |
| Dec 26, 2024 | 2024/0424121 | IMMUNOCONJUGATES AND METHODS | Pharmaceuticals | Zeno Management, Inc. · patent 12,280,121 granted from it |
| Dec 12, 2024 | 2024/0408225 | IMMUNOCONJUGATES AND METHODS | Pharmaceuticals | Zeno Management, Inc. |
| Dec 12, 2024 | 2024/0408224 | IMMUNOCONJUGATES AND METHODS | Pharmaceuticals | Zeno Management, Inc. · patent 12,274,754 granted from it |
| Mar 7, 2024 | 2024/0075153 | IMMUNOCONJUGATES AND METHODS | Pharmaceuticals | Zeno Management, Inc. · patent 12,186,403 granted from it |
| Oct 19, 2023 | 2023/0330242 | IMMUNOCONJUGATES AND METHODS | Pharmaceuticals | Zeno Management, Inc. · patent 11,806,405 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.